Global Chlorothiazide Sodium Injection Market Size, Share, and Trends Analysis Report, By Type (250 mg/Vial and 500 mg/Vial), By Application (Hospital, Clinics, and Others), Forecast (2022-2028)

The global chlorothiazide sodium injection market is anticipated to grow at a CAGR of 4.0% during the forecast period (2022- 2028). Chlorothiazide sodium for injection is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Chlorothiazide is a diuretic used for the treatment of high blood pressure (hypertension), as well as fluid retention in people with congestive heart failure, cirrhosis of the liver, kidney disorders, or edema caused by taking steroids or estrogen. Chlorothiazide is in a class of medications called diuretics (water pills). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine. Most often taken in pill form, it is usually taken orally once or twice a day. In the ICU setting, chlorothiazide is given to diurese a patient in addition to furosemide (Lasix). Working in a separate mechanism from furosemide and absorbed enterically as a reconstituted suspension administered through a nasogastric tube (NG tube), the two drugs potentiate one another.

The market is segmented based on the type and application. Based on the type, the market is sub-segmented into 250 mg/vial and 500 mg vial. Some major players in the market include Sun Pharmaceuticals Industries Ltd, Fresenius Kabi AG, and Sagent Pharmaceuticals, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships, new product launches, and collaborations, to stay competitive in the market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By  Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape– Sun Pharmaceuticals Industries Ltd., Fresenius Kabi AG, and Sagent Pharmaceuticals, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?

Global Chlorothiazide Sodium Injection Market Report by Segment

By Type

• 250 mg/Vial
• 500 mg/Vial

By Application

• Hospitals
• Clinics
• Others

Global Chlorothiazide Sodium Injection Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa